Joanne T. Beck serves as Executive at Orchard Therapeutics plc, where they oversee executive responsibilities. Since joining the company, Joanne T. Beck has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 24, 2024 involved selling 9,294 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 24, 2024 | ORTX | $0 | Disposition | 9,294 | $N/A | Discretionary |
Joanne T. Beck currently holds 0 shares of Orchard Therapeutics plc (ORTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joanne T. Beck has been a net neutral trader of ORTX stock. They have purchased $0 and sold $0 worth of shares.
Joanne T. Beck's most recent insider trade was on Jan 24, 2024, when they sold 9,294 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted